Daniel Loeb Avantor, Inc. Transaction History

Third Point LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$29.35 - $34.19 $245 Million - $286 Million	-8,360,000 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$32.56 - $40.56 $79.4 Million - $99 Million	-2,440,000 Reduced 22.59%	8,360,000 $283 Million
Q3 2021 Nov 15, 2021	BUY	$35.36 - $44.01 $10.6 Million - $13.2 Million	300,000 Added 2.86%	10,800,000 $442 Million
Q2 2021 Aug 16, 2021	SELL	$29.45 - $35.85 $14.7 Million - $17.9 Million	-500,000 Reduced 4.55%	10,500,000 $373 Million
Q4 2020 Feb 16, 2021	BUY	$22.9 - $28.15 $137 Million - $169 Million	6,000,000 Added 120.0%	11,000,000 $310 Million
Q3 2020 Nov 13, 2020	BUY	$16.99 - $22.79 $84.9 Million - $114 Million	5,000,000 New	5,000,000 $112 Million
Q2 2020 Aug 17, 2020	SELL	$11.78 - $19.24 $58.9 Million - $96.2 Million	-5,000,000 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$8.27 - $19.24 $16.5 Million - $38.5 Million	-2,000,000 Reduced 28.57%	5,000,000 $62.5 Million
Q4 2019 Feb 13, 2020	BUY	$13.63 - $18.56 $95.4 Million - $130 Million	7,000,000 New	7,000,000 $127 Million

573

645M

2.47M

8.7M

Ticker AVTR
Exchange NYSE
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 674,035,008
Market Cap $14.3B
Description
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulate...

Get notified when there are updates to the investment portfolio of Third Point LLC, based on Form 13F filings with the SEC.

Stay updated on Third Point LLC and Daniel Loeb with notifications on news.